Daratumumab versus lenalidomide as maintenance therapy in newly diagnosed multiple myeloma- Interim efficacy results of a randomized clinical trial Meeting Abstract
| Authors: | Rajeeve, S.; Derkach, A.; Devlin, S. M.; Santos, J.; Przemielewska, A.; Sood, T.; Maclachlan, K. H.; Hashmi, H.; Tan, C. R.; Korde, N.; Hultcrantz, M.; Dahi, P. B.; Lesokhin, A. M.; Scordo, M.; Chung, D. J.; Landau, H.; Shah, G. L.; Landgren, O.; Giralt, S. A.; Mailankody, S.; Usmani, S. Z.; Shah, U. A. |
| Abstract Title: | Daratumumab versus lenalidomide as maintenance therapy in newly diagnosed multiple myeloma- Interim efficacy results of a randomized clinical trial |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 3362 |
| Language: | English |
| ACCESSION: | WOS:001412651600024 |
| DOI: | 10.1182/blood-2024-208094 |
| PROVIDER: | wos |
| Notes: | Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
